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ABSTRACT
Aging is associated with oxidative stress-generated damage to DNA and this 
could be related to metabolic disturbances. This study investigated the association 
between levels of oxidatively damaged DNA in peripheral blood mononuclear cells 
(PBMCs) and metabolic risk factors in 1,019 subjects, aged 18-93 years. DNA damage 
was analyzed as strand breaks by the comet assay and levels of formamidopyrimidine 
(FPG-) and human 8-oxoguanine DNA glycosylase 1 (hOGG1)-sensitive sites There 
was an association between age and levels of FPG-sensitive sites for women, but 
not for men. The same tendency was observed for the level of hOGG1-sensitive 
sites, whereas there was no association with the level of strand breaks. The effect 
of age on oxidatively damaged DNA in women disappeared in multivariate models, 
which showed robust positive associations between DNA damage and plasma levels 
of triglycerides, cholesterol and glycosylated hemoglobin (HbA1c). In the group of 
men, there were significant positive associations between alcohol intake, HbA1c and 
FPG-sensitive sites in multivariate analysis. The levels of metabolic risk factors were 
positively associated with age, yet only few subjects fulfilled all metabolic syndrome 
criteria. In summary, positive associations between age and levels of oxidatively 
damaged DNA appeared mediated by age-related increases in metabolic risk factors.
INTRODUCTION
Aging is widely acknowledged to be associated 
with oxidative stress, typically referred to as the free 
radical theory of aging [1]. In addition, oxidative stress 
is implicated in age-related diseases such as cancer and 
cardiovascular diseases [2]. Oxidative stress-generated 
damage to DNA may be due to a declining activity of the 
antioxidant defense and repair systems or increased level 
of pro-oxidant factors, or both [3]. The most commonly 
investigated oxidative stress-generated DNA nucleobase 
lesion is 8-oxo-7,8-dihydroguanine (8-oxoGua) that 
is also one the most common pre-mutagenic lesions 
in the genome. This lesion can be measured by mass 
spectrometry after chromatographic isolation, although 
it is more common to measure the 2’-deoxyguanosine 
analogue 8-oxo-7,8-dihydro-2’-deoxyguanosine 
(8-oxodG) by either mass spectrometry or electrochemical 
detection. Alternatively, enzymic detection of oxidized 
purines, including 8-oxoGua by formamidopyrimidine 
DNA glycosylase (FPG) has been widely used in 
biomonitoring studies [4]. It has been shown that there 
is a positive association between age and increased 
level of FPG-sensitive sites in leukocytes from humans 
[5;6], whereas no associations between the level of FPG-
sensitive sites and age, sex or smoking status have been 
reported in cross-sectional studies [7;8].
The DNA in human cells is oxidatively damaged by 
various endogenous biochemical processes, but exposure 
to hazardous environmental compounds and lifestyle 
factors are also important determinants for levels of 
oxidatively damaged DNA [4]. An excessive energy intake 
and sedentary lifestyle are associated with obesity and 
metabolic syndrome, which has high prevalence in both 
Europe and USA [9-11]. Metabolic syndrome is defined by 
the presence of a number of risk factors for cardiovascular 
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diseases, including glucose intolerance, hypertension, 
hyperlipidemia, insulin resistance and obesity [12]. These 
and similar metabolic risk factors, such as increased levels 
of glycosylated hemoglobin (HbA1c), accumulate with age. 
It has been shown that hyperlipidemia is associated with 
elevated levels of oxidatively damaged DNA in peripheral 
blood mononuclear cells (PBMCs) [13]. Obesity, the 
metabolic syndrome and type 2 diabetes mellitus are 
associated with elevated levels of oxidative stress and low-
grade inflammation [14]. Indeed, a positive association 
between the body mass index (BMI, i.e. the body weight 
in kilograms divided by the square of the height in meters) 
and elevated levels of FPG-sensitive sites in lymphocyte 
has been reported in a study of young and healthy subjects 
[15]. It has been shown that patients with type 2 diabetes 
mellitus or vascular disease had higher levels of 8-oxodG 
in lymphocytes than healthy subjects [16;17]. Another 
study showed that patients with essential hypertension had 
higher levels of 8-oxodG in leukocytes than subjects with 
normal blood pressure at the same age and body weight, 
although it should be noted that the statistical analysis did 
not control for metabolic or lifestyle factors [18]. Potential 
lifestyle factors of importance include a number of self-
inflicted exposures such as alcohol intake, smoking and 
dietary components that may explain inter-individual 
variation in the basal level of DNA damage [19-22]. 
The objective of this study was to investigate the 
association between aging, metabolic risk factors and 
levels of oxidative damage to DNA in PBMCs from 
healthy subjects in the general population. In this respect, 
“healthy” implies that the subjects did not have specific 
diseases, although it is nowadays difficult to find subjects 
in the elderly population in countries with a proficient 
healthcare system, who are not “patients” in one way or 
another. We used PBMCs because they circulate through 
all organs of the body and they can be obtained from 
healthy humans. In addition, dysfunction of PBMCs is 
observed in age-related immune senescence, and aging-
related telomere shortening in circling leukocytes have 
been observed in human cross-sectional and longitudinal 
studies [23;24]. The present study had a sufficient number 
of subjects to discriminate between aging per se and other 
contributing factors. As a rule of thumb, there should be 
approximately 100 observations for each independent 
variable in a multi-factorial analysis. We sampled blood 
from 1,019 subjects, allowing 10 independent variables 
in the statistical analysis. Our study was part of a cross-
sectional study that had focus on lifestyle factors including 
diet, smoking, alcohol and physical activity [25]. The 
information about these variables was obtained by self-
administered questionnaires, standard blood tests and 
physical performance tests. We hypothesized that there 
would be an association between age and levels of DNA 
damage in PBMCs which could be explained by metabolic 
risk factors. 
RESULTS
We analyzed the level of DNA damage in PBMCs 
from 1,019 subjects. There was missing information from 
the questionnaire data from 26 subjects. The effective 
study size was therefore 993 subjects, although there was 
also missing information for some of dependent variables 
in this dataset. The results on sex, obesity (BMI or waist-
hip ratio (WHR, i.e. the ratio of body circumferences 
at the waist and the hip)), blood pressure, plasma lipids 
(cholesterol and triglycerides), HbA1c, C-reactive protein 
(CRP) smoking, alcohol intake and cardiorespiratory 
fitness in age-stratified groups, are shown in Table 1. In 
univariate linear regression analysis (Table 2), there were 
age-dependent positive associations in both sexes between 
age and BMI (P<0.001), WHR (P<0.001), cholesterol 
(P<0.001), triglycerides (P<0.001), HbA1c (P<0.001), 
systolic blood pressure (P<0.001), diastolic blood pressure 
(P<0.001). There was an inverse association between age 
and cardiorespiratory fitness (P<0.001) and the CRP level 
was not associated with age (P>0.05).
There were positive associations between age 
and levels of both FPG- and human 8-oxoguanine 
DNA glycosylase 1 (hOGG1)-sensitive sites for women 
(P<0.001), but not for men (P>0.05), in univariate linear 
regression analysis. Figure 1 shows the level of oxidatively 
damaged DNA in age-stratified groups. Both the FPG- 
and hOGG1-sensitive sites were elevated in the groups of 
women at the age of 50-69 yr (P<0.05, ANOVA) and 70-
93 yr (P<0.01, ANOVA) as compared to the women in the 
youngest age group. There was no association between age 
and levels of DNA strand breaks (Supplementary Figure 
1).
Univariate regression analysis showed that the 
level of FPG-sensitive sites was associated with levels 
of cholesterol, triglycerides, HbA1c and alcohol intake 
in either one or both sexes (Table 3). The multivariate 
regression analysis showed associations between FPG-
sensitive sites and plasma levels of cholesterol (P<0.01) 
and triglycerides (P<0.05) among women. Figure 2 and 3 
show the level of FPG-sensitive in groups of subjects who 
have been stratified for plasma level of cholesterol and 
triglycerides, respectively. The linear regression analysis 
indicated associations between FPG-sensitive sites and 
HbA1c in both men (P<0.05) and women (P<0.001), 
although it is clear that the association was strongest in the 
women as also indicated on the ANOVA test (Figure 4). 
The association between FPG-sensitive sites and alcohol 
intake was strongest among men (P<0.05). Figure 5 shows 
the level of FPG-sensitive sites in subjects who have been 
stratified into groups according to the level of alcohol 
intake. There was also a modest positive association in 
the whole group of subjects between the level of WHR 
and FPG-sensitive (P<0.05), although this was not robust 
in multivariate regression analysis. Figure 6 shows the 
level of FPG-sensitive sites in groups of subjects stratified 
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Table 1: Metabolic, physiological and lifestyle variables of the study participants in age-stratified groups
Variable Total 18-29 yr 30-49 yr 50-69 yr 70-93 yr
Sex (Men/women) 387/605 45/95 148/223 148/215 46/72
BMI (kg/m2) 24.2±0.11 (993)
22.2±0.21 
(140)
23.8±0.16 
(372)
24.9±0.20 
(363)
25.6±0.33 
(118)
WHR 0.87±0.01 (993)
0.82±0.01 
(140)
0.85±0.01 
(372)
0.89±0.01 
(363)
0.91±0.01 
(118)
Diastolic blood pressure (mmHg) 79±0.3 (993)
74±0.7 
(140)
78±0.5 
(372)
83±0.6 
(363)
79±1.0 
(118)
Systolic blood pressure (mmHg) 124±0.5 (993) 
117±1.0 
(140)
120±0.7 
(372)
128±1.0 
(363)
133±1.6 
(118)
Mean arterial blood pressure (mmHg) 94±0.4 (993)
88±0.7 
(140)
92±0.5 
(372)
98±0.6 
(363)
97±1.1 
(118)
Cholesterol (mmol/L) 5.24±0.03 (993)
4.60±0.07 
(140)
4.94±0.05 
(372)
5.69±0.05 
(363)
5.54±0.09 
(118)
Triglycerides (mmol/L) 1.54±0.03 (993)
1.36±0.07 
(140)
1.44±0.04 
(372)
1.68±0.04 
(363)
1.59±0.07 
(118)
CRP (mg/L) 2.17±0.18 (993)
2.56±0.40 
(139)
1.70±0.29 
(372)
2.11±0.30 
(363)
3.34±0.47 
(118)
HbA1c (%)
5.38±0.01 
(991)
2.13±0.02 
(139)
5.28±0.02 
(371)
5.51±0.02 
(363)
6.71±0.05 
(118)
Smoking (Nonsmoker/smoker) 557/436 105/35 231/141 157/206 64/54
Alcohol intake (drinks per week) 10 ± 0.3 (971)
10±0.7 
(135)
7 ± 0.3 
(366)
12 ± 0.6 
(357)
11±1.0 
(113)
Cardiorespiratory fitness (mL/min/kg) 36±0.3 (722)
41±0.6 
(133)
39±0.4 
(338)
31±0.5 
(224)
25±1.0 
(27)
BMI: body mass index, WHR: waist-hip ratio, CRP: C-reactive protein. The values are mean ± SEM (number of subjects).
Figure 1: Levels of oxidatively damaged DNA in PBMCs from subjects in different age groups of men (A and C) and 
women (B and D). The number of subjects in the age groups are 45/95 (18-29 yr), 148/223 (30-49 yr), 148/215 (50-69 yr) and 46/72 
(70-93 yr) for men/women. The bars and whiskers are means and SEM. 
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Table 2: Associations between age, metabolic and lifestyle factors and physiological variables.
The values are r-values of univariate linear regression analysis. *P<0.001, #P<0.01, §P<0.05. Values to the left and right of the 
shaded ladder are r-values in the strata of men and women, respectively. ALC: alcohol intake, BMI: body mass index, CHO: 
cholesterol, CRF: cardiorespiratory fitness, MAP: mean arterial blood pressure; TRI: triglycerides; WHR: waist-hip ratio.
Table 3: Results of regression analysis for age and metabolic and lifestyle factors as predictors of 
the level of FPG-sensitive sites 
Variable All Men Women
Age 0.99 (0.33)# 0.37 (0.56) 1.36 (0.41)*
Sex 2.57 (11.1) NA NA
BMI 2.04 (1.56) -1.09 (2.78) 3.63 (1.92)
WHR 127 (65)§ 180 (120) 161 (105)
MAP 0. 27 (0.33) 0. 51 (0.59) 0. 14 (0.40)
Cholesterol 16.0 (5.5)# 12.4 (8.9) 18.8 (7.0)#
Triglycerides 13.6 (6.6)§ 5.89 (9.24) 23.2 (9.7)§
HbA1c 52.6 (13.4)* 42.5 (19.2)§ 63.3 (19.0)*
CRP 0.87 (0.99) 0.28 (1.53) 1.35 (1.32)
Smoking -3.72 (10.9) -6.47 (18.0) -2.27 (13.9)
Alcohol 1.30 (0.60)§ 1.88 (0.86)§ 0.72 (0.93)
The data are reported as slope and standard error (per 103). §P<0.05, #P<0.01 or *P<0.001 (univariate linear 
regression analysis). Bold numbers indicate variables with statistically significantly effect in stepwise 
forward and backward multi-variable regression analysis. BMI: body mass index, WHR: waist-hip ratio, 
MAP: mean arterial blood pressure, CRP: C-reactive protein, NA: not applicable. 
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Table 4: Results of regression analysis for age and metabolic and lifestyle factors as 
predictors of the level of hOGG1-sensitive sites
Variable All Men Women
Age 0.27 (0.17) -0.03 (0.30) 0.44 (0.20)§
Sex 7.55 (5.66) NA NA
BMI 0.87 (0.79) 0.21 (1.50) 0.93 (0.93)
WHR 39.6 (32,7) -7.29 (64.4) 44.6 (50.5)
MAP 0.31 (0.17) 0.12 (0.31) 0.35 (0.19)
Cholesterol 0.80 (2.8) -1.71 (4.80) 3.00 (3.39)
Triglycerides 7.52 (3.32)§ 3.46 (4.97) 11.3 (4.69)§
HbA1c 9.12 (6.84) 1.74 (10.3) 16.9 (9.23)
CRP 0.23 (0.50) 1.05 (0.82) -0.46 (0.63)
Smoking -2.85 (5.59) -17.1 (9.61) 5.63 (6.75)
Alcohol 0.14 (0.31) -0.03 (0.47) 0.11 (0.45)
The data are reported as slope and standard error (per 103). §P<0.05 (univariate linear 
regression analysis). Bold numbers indicate variables with statistically significantly effect in 
stepwise forward and backward multi-variable regression analysis. BMI: body mass index, 
WHR: waist-hip ratio, MAP: mean arterial blood pressure, CRP: C-reactive protein, NA: 
not applicable.
Figure 3: Levels of FPG-sensitive sites in PBMCs from subjects stratified into groups of plasma triglycerides 
concentrations being less than the 25% quartile, middle or more the 75% quartile for the sex. These groups were <0.95 
(n = 151), 0.95 – 1.67 (n = 303) and >1.67 (n = 151) for the women. For men, these groups were <1.11 (n = 97), 1.11 – 2.07 (n = 194) and 
>2.07 (n = 96). The bars and whiskers are means and SEM. The P-values correspond to ANOVA tests with group as categorical variable.
Figure 2: Levels of FPG-sensitive sites in PBMCs from subjects stratified in plasma cholesterol concentrations being 
less than the 25% quartile, middle or more the 75% quartile for the sex. These groups were <4.58 (n = 150), 4.58-5.95 (n = 
303) and >5.95 (n = 152) for the women. For men, these groups were <4.39 (n = 94), 4.39-5.77 (n = 196) and >5.77 (n = 97). The bars and 
whiskers are means and SEM. The P-values correspond to ANOVA tests with group as categorical variable.
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Figure 4: Levels of FPG-sensitive sites in PBMCs from subjects stratified into plasma levels of HbA1c being less than 
the 25% quartile, middle or more the 75% quartile for the sex. These groups were <5.2 (n = 137), 5.2 – 5.6 (n = 367) and >5.6 
(n = 99) for the women. For men, these groups were <5.2 (n = 86), 5.2 – 5.6 (n = 212) and >5.5 (n = 89). The bars and whiskers are means 
and SEM. The P-values correspond to ANOVA tests with group as categorical variable.
Figure 5: Levels of FPG-sensitive sites in PBMCs from subjects stratified into groups of alcohol intake being less than 
the 25% quartile, middle or more the 75% quartile for the sex. These groups were <2 (n = 111), 2 – 11 (n = 345) and >11 (n = 
133) for the women. For men, these groups were <5 (n = 90), 5 - 19 (n = 199) and >19 (n = 92). The bars and whiskers are means and SEM. 
The P-values correspond to ANOVA tests with group as categorical variable.
Figure 6: Levels of FPG-sensitive sites in PBMCs from subjects stratified into WHR level being less than the 25% 
quartile, middle or more the 75% quartile for the sex. These groups were <0.78 (n = 151), 0.78 – 0.87 (n = 303) and >0.87 (n = 
151) for the women. For men, these groups were <0.87 (n = 95), 0.87 – 0.97 (n = 196) and >0.97 (n = 96). The bars and whiskers are means 
and SEM. The P-values correspond to ANOVA tests with group as categorical variable.
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according to the level of WHR; the difference in WHR was 
statistically significant in the overall ANOVA (P<0.001), 
whereas there was no association between BMI and levels 
of FPG-sensitive sites (Supplementary Figure 2).
The level of hOGG1-sensitive sites was associated 
with age in women (Figure 1), whereas there only was 
association between the level of hOGG1-sensitive sites 
and plasma concentration of triglycerides in univariate 
regression analysis (Table 4). This association remained 
statistically significant in multivariate regression analysis 
in both sexes (P<0.05, Table 4). However, the association 
was mainly driven by the association among the women, 
whereas the ANOVA test on categorized triglyceride 
levels also indicated positive associations between plasma 
triglyceride levels and hOGG1-sensitive sites among men 
(Figure 7). There were no associations between levels of 
hOGG1-sensitive sites and BMI (Supplementary Figure 3) 
or WHR (Supplementary Figure 4).
There was no difference between subjects, who 
fulfilled all defined criteria for metabolic syndrome, and 
controls in terms of DNA strand breaks (0.18 ± 0.01 versus 
0.18 ± 0.02 lesions/106 bp, P=0.34), FPG-sensitive sites 
(0.52 ± 0.02 versus 0.50 ± 0.02 lesions/106 bp, P=0.97), 
and hOGG1-sensitive sites (0.12 ± 0.01 versus 0.13 ± 0.01 
lesions/106 bp, P=0.80), respectively.
DISCUSSION
In this study we showed an association between 
age and levels of oxidatively damaged DNA particularly 
in women, whereas the same trend was not significant 
among men. Figure 8 depicts a schematic overview of the 
associations between age and oxidatively damage DNA 
in PBMCs, highlighting the effects of possible mediators. 
There were associations between age and blood pressure, 
obesity, plasma lipids and HbA1c and alcohol intake, 
whereas the cardiorespiratory fitness was inversely 
associated with age. The association between age and 
oxidatively damaged DNA disappeared in multivariate 
regression analysis models, which showed robust 
associations between levels of oxidatively damaged DNA 
and measures of plasma lipids, HbA1c and alcohol intake. 
These results indicate that the positive association between 
age and level of oxidatively damaged DNA was mediated 
by metabolic and lifestyle factors rather than the aging 
process per se. The multivariate analysis also indicated 
that measures of blood pressure and obesity were not 
associated with the level of oxidatively damaged DNA.
The results demonstrate sex differences in age-
related levels of DNA damage and effect of potential 
mediators. This is most likely based on multiple factors, 
some of which are related to specific exposures. For 
instance, the strongest effect of alcohol intake was 
observed in the strata of men, which had both higher 
mean intake and standard deviation (12.6 ± 10.7 drinks per 
week) as compared to women (7.4 ± 7.5 drinks per week). 
The effect of metabolic risk factors may also display sex-
dependent trends because there are biological differences 
between men and women. However, it should also be 
acknowledged that most of the metabolic risk factors 
are proxy-measures of biological features. For instance, 
both BMI and WHR are descriptors of obesity, but the 
r-values between BMI and WHR were only 0.61 and 0.45 
in men and women in the present dataset, respectively. 
The relatively low correlation coefficient between BMI 
and WHR indicates that there are several ways of being 
obese and this may be sex-dependent. The stronger effect 
of metabolic risk factors in the strata of women might be 
due to the larger number of women in the dataset, although 
this should not affect the size of regression coefficients. 
Figure 7: Levels of hOGG1-sensitive sites in PBMCs from subjects stratified into serum levels of triglycerides being 
less than the 25% quartile, middle or more the 75% quartile for the sex. These groups were <0.95 (n = 151), 0.95 – 1.67 (n 
= 303) and >1.67 (n = 151) for the women. For men, these groups were <1.11 (n = 97), 1.11 – 2.07 (n = 194) and >2.07 (n = 96). The bars 
and whiskers are means and SEM. The P-values correspond to ANOVA tests with group as categorical variable.
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Finally, sex-specific interactions between metabolic 
risk factors might explain why some trends are stronger 
displayed only in one sex. For instance, plasma levels 
of triglycerides and cholesterol correlate significantly in 
both men and women, whereas there is only a significant 
correlation between these plasma lipids and HbA1c in 
men. We have not sought to unravel interactions between 
metabolic risk factors and levels of DNA damage because 
the dataset most likely will be statistically under-powered 
in such analysis.
It has been shown that circulating PBMCs from 
obese subjects displayed a pro-inflammatory phenotype 
[26]. A pro-inflammatory state in obesity can be associated 
with oxidative stress by for instance increased activity 
NADPH oxidase [27].We observed a positive association 
between CRP levels and obesity measures (BMI or WHR) 
in univariate linear regression model. However, there 
were relatively few subjects in the present study who 
were obese (BMI > 30 kg/m2) and there were only weak 
associations between measures of obesity and oxidatively 
damaged DNA in PBMCs. A previous study showed a 
positive association between BMI and FPG-sensitive sites 
in lymphocytes of non-obese women aged 19-31 years, 
whereas there were no association in men [15]. However, 
a cross-sectional study of mainly non-obese subjects in 
Florence, Italy, showed no association between the BMI 
and FPG-sensitive sites [20].
Our results point to an effect of the plasma levels 
of triglycerides, rather than obesity, on the level of 
oxidatively damaged DNA in PBMCs. The positive 
association between the level of triglycerides and 
oxidatively damaged DNA in PBMCs was robust after 
adjustment for variables related to obesity (BMI and 
WHR). It indicates that the association could be related 
directly to an effect of the lipids, rather than the level 
of triglycerides being a proxy-measure of a non-lipid 
variable with DNA damaging potential. This is supported 
by a study of patients with hyperlipidemia who had 
a positive correlation between levels of 8-oxodG in 
PBMCs and plasma levels of triglycerides and insulin 
resistance, whereas there were no correlation with BMI 
and abdominal circumference [13]. The measurement of 
triglycerides in plasma mainly represents lipids stored 
in lipoproteins, which is considered to be less hazardous 
than non-esterified free fatty acids [28;29]. Nevertheless, 
it has been shown that there is a correlation between 
triglycerides and non-esterified fatty acids in women, 
whereas no such association was observed in men [30]. 
This could explain the stronger association between 
plasma lipids and oxidatively damaged DNA in our study. 
Another study showed a positive correlation between DNA 
strand breaks, although not FPG-sensitive sites, in PBMCs 
and concentrations palmitic acid, decosahexaenoic acid, 
linoleic acid and oleic acid in erythrocytes [31]. The non-
esterified free fatty acids in blood originate from lipolysis 
in adipocytes and elevated levels of these lipids have 
been associated with hepatic oxidative stress and insulin 
resistance [32]. This is supported by experimental studies 
showing that infusion of triglycerides in the circulation of 
healthy humans was associated with oxidative stress and a 
pro-inflammatory state in PBMCs [33].
The linkage between high blood glucose levels 
and oxidative damage to DNA in lymphocytes is 
well established for diabetics [16]. In addition, it has 
Figure 8: Associations between age, mediators and oxidatively damaged DNA in PBMCs in the present study. Arrows 
represent pathways with the strongest statistically significant effect in univariate models. The sex symbols (♀ or ♂) indicate associations 
between pre-diabetes mellitus (preDM/HbA1c), triglycerides, cholesterol or alcohol intake is either both or only one sex strata.
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been described that there is an association between 
the glycemic status and oxidatively damaged DNA in 
PBMCs in well-controlled diabetes patients [34]. We 
used the plasma HbA1c as a marker of the average blood 
glucose concentration during the last three months. The 
Danish threshold for type 2 diabetes is 6.5% HbA1c 
(corresponding to 48 mmol/mol or a mean glucose level 
of 7.7 mmol/L), whereas a level of 6.0-6.5% is considered 
to be an indication of pre-diabetic status. By this standard 
there were 13 subjects (1.3%) having pre-diabetic status 
or type 2 diabetes mellitus in our study. Nevertheless, 
our study shows a robust association between the level of 
HbA1c and FPG-sensitive sites below the threshold of pre-
diabetes, suggesting that this can be part of the mediation 
of age-related accumulation of DNA damage.
The strongest associations (i.e. highest slopes in 
the regression analysis) between metabolic risk factors 
and levels of oxidatively damaged DNA were observed 
in the strata of women for obesity, HbA1c, triglycerides 
and cholesterol. Interestingly, a previous study showed 
no difference in levels of hOGG1-sensitive sites in 
leukocytes of age-matched (average 47 years) subjects 
with metabolic syndrome and controls [35]. It has been 
shown that obesity and diabetes are associated with risk 
of cancer is several organs and the risk is sex-dependent 
[36;37]. Likewise, blood glucose and triglycerides levels 
have been associated with increased risk of cancers that 
differ between the sexes [38;39], whereas elevated serum 
levels of cholesterol has been shown to be inversely 
associated with cancer risk [40]. It should be noted 
that these epidemiological studies have not adjusted 
for other important types of metabolic risk factors and 
residual confounding is possible. However, it worthwhile 
noting that the different strength of association and sex-
related differences between metabolic risk factors and 
levels of oxidatively damaged DNA, is also observed in 
epidemiology on disease endpoints.
The subjects in the present study were relatively fit 
physically and healthy. It has been shown that men with 
low aerobic fitness had high age-related accumulation in 
FPG-sensitive sites in lymphocytes (r = 0.74) as compared 
with men with high aerobic fitness (r = 0.32), assessed 
by VO2max measurements [41]. However, a positive 
correlation between VO2max and levels of FPG-sensitive 
sites in PBMCs has also been observed in a cross-sectional 
study on subjects aged 20 to 84 years [42]. Nevertheless we 
have found no association between physical performance 
(determined as maximal jump force, handgrip strength and 
number of rises from a chair in 30 sec) and FPG-sensitive 
sites in PBMCs from the middle-aged, all born in 1953 
in the Copenhagen Metropolitan area [43]. The level of 
physical fitness in the study populations may explain the 
apparent discrepancy between studies showing no effect of 
age and age-related accumulation in oxidatively damaged 
DNA, although this parameter is not usually assessed in 
cross-sectional studies.
Diet can be regarded as a complex mixture of 
components having beneficial (e.g. antioxidants) or 
hazardous mechanisms (pro-oxidant compounds). We 
have not assessed the effect of specific dietary items in 
this study. It should be acknowledged that dietary habits 
(or specific components) may be uncontrolled confounders 
as well as mediators. It has been shown that the level 
of 8-oxodG in leukocytes was positively associated 
with age (20-90 years) and it correlated positively with 
some plasma antioxidants (vitamin E and uric acid) and 
negatively with other (ascorbic acid) antioxidants [44]. 
Observations from a cross-sectional study with 340 
subjects in Oslo, Norway, showed an inverse association 
between levels of FPG-sensitive sites in PMBCs and 
habitual fruit intake, whereas there were no significant 
associations with a number of biomarkers of antioxidant 
status in plasma [45]. A cross-sectional study on 201 
inhabitants in Bremen, Germany, found no association 
between the level of FPG-sensitive sites and age, sex or 
smoking status [7]. Nevertheless, several intervention 
studies have shown that supplementation with antioxidant-
rich food items was associated with reduced levels of 
oxidatively damaged nucleobase products in leukocytes 
and urine [46;47]. However, dietary interventions with 
substitution to food rich in fruits and vegetables had 
little effect on the level of oxidatively damaged DNA 
in PBMCs [48;49]. Even though associations are at best 
weak between oxidatively induced DNA damage and 
a diet rich in fruits and vegetable, which would also be 
expected to reduce obesity, plasma lipids and Hb1Ac, we 
cannot exclude confounding from that aspect of diet.
The positive association between age and levels of 
oxidatively damaged DNA is in keeping with the notion 
that aging is associated with oxidative stress because of 
reduced activity of the antioxidant system or increased 
production of reactive oxygen species [1;2] and this could 
partly by mediated by metabolic factors as suggested 
by our study. There is compelling evidence from animal 
experimental models that the levels of oxidatively 
damaged DNA in tissues are associated with the age [50], 
which could be a pro-oxidant effect as well as a reduced 
activity of the DNA repair system [51]. The studies on 
aging in small rodents are relatively straightforward 
because of the short lifespan, whereas the long lifespan 
of humans typically allows only cross-sectional types 
of studies as our study. In such a design, one compares 
subjects with different age and possibly also different 
lifestyles. In addition, selection bias is difficult to avoid 
because of voluntary participation. This is also an issue 
in the present study, considering limited participation 
(11.6% of all invited persons in the area), suggesting a 
selection bias toward more health conscious participants. 
However, the strength of our study is the large number of 
subjects, which makes it possible to assess some of the 
age-related lifestyle and metabolic factors as mediators of 
DNA damage.
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In summary, there was an association between age 
and levels of FPG- and hOGG1-sensitive sites in particular 
among women, whereas the association was not significant 
for men. The accumulation of DNA damage with age 
could be mediated by metabolic factors including plasma 
lipids and HbA1c as well as intake of alcohol which was 
positively associated with age and showed significant 
robust positive associations with the levels of oxidatively-
induced DNA damage. 
METHODS 
Sampling
We collected blood samples and lifestyle related 
data from 1,019 subjects in Copenhagen during a 
national survey of the health status in thirteen different 
municipalities around Denmark [25]. Our collection 
of samples took place in September 2008 among 1,739 
participants in the municipality of Frederiksberg which 
had a participation rate of 11.6% of the invited adult 
population. The sampling for the present study ceased 
after having collected blood from the first thousand 
subjects. Approximately 100 subjects were invited to 
participate per day and were subjected to a full health 
examination, including anthropometric and other 
health related measurements. There were no inclusion 
or exclusion criteria in our sampling, which included 
randomly selected men and women aged 19-93 years. We 
obtained 7 mL venous blood in cell preservation tubes 
(Vacutainer, Becton Dickinson A/S, Brøndby, Denmark) 
from each subject, isolated and cryopreserved the PBMCs 
(for comet assay) in a solution with 50% fetal bovine 
serum, 40% RPMI medium and 10% dimethyl sulphoxide 
as described in a previous study [52]. 
From the questionnaires, we obtained information 
about age, sex, alcohol intake and smoking status. The 
physical examination included determination of BMI, 
WHR, blood pressure and cardiorespiratory fitness 
tested on an ergometer bike as an indirect maximal or 
sub-maximal exercise test [25]. Non-fasting venous 
blood plasma samples were analyzed for cholesterol, 
triglyceride, CRP and HbA1c at the Department of Clinical 
Biochemistry, KB 3-01-1, Rigshospitalet, Copenhagen 
University Hospital.
Oxidatively damaged DNA
The level of DNA damage in PBMCs was analyzed 
by the single cell gel electrophoresis (comet) assay as 
strand breaks, FPG- and hOGG1-sensitive sites. The FPG- 
and hOGG1-sensitive sites are oxidatively damaged DNA 
in terms of ring-opened formamidopyrimidine lesions and 
8-oxodG, whereas the FPG enzyme can also detect non-
oxidatively generated DNA lesions following exposure to 
high doses/concentrations of alkylating agents [53;54].
A 150 µL of the cryopreserved PBMC suspension 
was mixed with 1000 µL low melting point agarose 
(0.75 % in PBS, Sigma-Aldrich) at 37 oC and 60 µL was 
applied to GelBonds (Cambrex, Medinova Scientific A/S, 
Hellerup, Denmark). The Gelbonds were transferred to 
lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM 
Trizma base, pH 10.0) for at least one hour. The FPG 
enzyme (1 mg/mL, gift from Professor Andrew Collins, 
University of Oslo, Norway), hOGG1 (0.16 units/gel, 
Medinova Scintific A/S, Denmark (P/N M0241L)) or a 
solution consisting of 40 mM HEPES, 0.1 M KCl, 0.5 mM 
Na2EDTA, 200 μg/mL BSA, pH 8.0 was applied onto the 
gels and they were covered with cover slip and incubated 
for 45 min at 37 oC in a humidified box. The Gelbonds 
were transferred to the electrophoresis chamber containing 
an alkaline solution (1 mM Na2EDTA, 300 mM NaOH, pH 
13.0) and left for 40 min at 4 oC. Electrophoresis time was 
20 min (25 V, 300 mA, 0.83 V/cm) in the same solution as 
alkaline unwinding treatment. The samples subsequently 
were neutralized by three times 5 min washing in 
neutralization buffer (0.4 M Trizma base, pH 7.5), rinsed 
with milliQ® water and dried in 96 % ethanol.
We had reference control samples in each 
experiment (corresponding to one electrophoresis) that 
included one aliquot of PBMCs that had been exposed 
to the photosensitizer Ro19-8022 and white light, which 
generates high levels of FPG-sensitive sites. The Ro19-
8022 photosensitizer was a kind gift from F. Hoffmann-
La Roche (Basel, Switzerland). The mean ± standard 
deviation of the controls were 0.36 ± 0.17, 0.59 ± 0.20 and 
1.07 ± 0.17 lesions/106 bp for levels of DNA strand breaks, 
hOGG1- and FPG-sensitive sites, respectively.
The dried samples was stained with YOYO-1 iodide 
(P/N 491/509, Molecular Probes, The Netherlands) in 
PBS and 100 images per slide was scored (200 images 
per subject) using an Olympus fluorescence microscope 
at 40x magnification by using a five-class scoring 
system (arbitrary score range: 0-400). These scores were 
transformed to lesions per 106 base pairs (bp) by means of 
a calibration curve based on induction of strand breaks by 
ionizing radiation, which has a known yield. We used a 
conversion factor of 0.0298 Gy equivalents per score and 
calculations were based on the assumption that an average 
molecular weight of a DNA bp is 650 Dalton [55]. The 
number of FPG- or hOGG1-sensitive sites was obtained 
as the difference in scores of parallel slides incubated with 
FPG, hOGG1 or buffer, respectively. 
Statistics
We used univariate and multivariate regression 
models including the following independent variables: 
age, sex, smoking, alcohol intake, obesity (BMI or 
WHR), cardiorespiratory fitness, blood pressure, plasma 
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levels of lipids (cholesterol or triglycerides), HbA1c and 
CRP with strand breaks, FPG- and hOGG1-sensitive 
sites as dependent variables. The associations between 
the independent variables were assessed in univariate 
regression models. We used the mean arterial blood 
pressure (MAP) in the statistical models because the 
systolic and diastolic blood pressure was strongly 
correlated (r = 0.71, P<0.001, linear regression). This 
was defined as: MAP = [(2 x diastolic pressure) + systolic 
pressure]/3. The statistical models included either BMI 
or WHR as measure of obesity because these were 
correlated (r = 0.51, P<0.001, linear regression). We 
have included only BMI in the multivariate regression 
models. The level of cardiorespiratory fitness (i.e. the 
maximal oxygen consumption VO2max determined in an 
exercise test) has been assessed as a descriptive variable 
of the subject’s health status, whereas it is not included 
in multivariate regression analysis because of possible 
selection bias in the elderly. The health examination 
included also measurements of hand grip strength with 
observations in 993 subjects; in comparison there were 
measurements of VO2max in 722 subjects. The group of 
subjects who had not done the exercise test had a stronger 
inverse association between age hand grip strength test 
as compared to the group of subjects who had done the 
exercise test (P<0.01 for interaction between age and 
performance of exercise test).
The multivariate linear regression analysis included 
the age, sex, MAP, BMI, cholesterol, triglycerides, CRP, 
HbA1c, alcohol intake and smoking status with both 
forward and backwards variable selection. Variables 
that were statistically significant in multivariate 
regression analysis were also analyzed in ANOVA tests 
on categorized data (age, cholesterol, triglycerides and 
alcohol intake). The groups were defined as low (less 
than the 25% quartile), middle, and high (more than the 
75% quartile) of the determining variable. The effect 
of the metabolic syndrome was assessed by stratifying 
the subjects into two categories with or without this 
condition. The criteria used for identifying subjects 
with metabolic syndrome were a modified version of 
the WHO standards [56]. The cut-off values defined by 
the WHO on three main criteria; obesity, hypertension 
and triglycerides were applied as follows. Obesity; BMI 
>30 kg/m2 or WHR >0.90 for men and >0.85 for female. 
Hypertension; systolic pressure >140 mmHg, diastolic 
pressure >90 mmHg, triglycerides ≥1.7 mmol/L. Subjects 
were identified as having metabolic syndrome when they 
expressed elevated values in all three criteria. There were 
relatively few subjects with metabolic syndrome and 
it seemed to depend on both age and sex. We therefore 
assessed the effect of metabolic syndrome in subjects with 
a control group that was matched for age, sex (with a six 
years span) and day of analysis of DNA damage. Thus 
selection yielded 94 pairs of subjects and the effect of 
metabolic syndrome was analyzed by the Students t-test. 
All statistical analysis were performed in SAS 
institute 9.1.9 or Statistical version 5.5 from StatSoft, Inc., 
Tulsa, OK, USA and statistical significance was defined 
as P< 0.05.
ABBREVIATIONS
BMI: body mass index, CRP: C-reactive protein, 
MAP: mean arterial pressure, PBMC: peripheral blood 
mononuclear cell, 8-oxoGua: 8-oxo-7,8-dihydroguanine, 
8-oxodG: 8-oxo-7,8-dihydro-2’-deoxyguanosine, 
FPG: formamidopyrimidine DNA glycosylase, OGG1: 
8-oxoguanine DNA glycosylase 1, WHR: waist-hip ratio.
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